{
    "paper_id": "6872b1c443a4cfbdc1b4c18bfbdedf78cac72a14",
    "metadata": {
        "title": "IL-6 may be a good biomarker for earlier detection of COVID-19 progression",
        "authors": [
            {
                "first": "Changsong",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Harbin Medical University",
                    "location": {
                        "postCode": "150081",
                        "settlement": "Harbin, Heilongjiang",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Dongsheng",
                "middle": [],
                "last": "Fei",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Harbin Medical University",
                    "location": {
                        "postCode": "150081",
                        "settlement": "Harbin, Heilongjiang",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Xueting",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Harbin Medical University",
                    "location": {
                        "postCode": "150081",
                        "settlement": "Harbin, Heilongjiang",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Mingyan",
                "middle": [],
                "last": "Zhao",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Harbin Medical University",
                    "location": {
                        "postCode": "150081",
                        "settlement": "Harbin, Heilongjiang",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Kaijiang",
                "middle": [],
                "last": "Yu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Harbin Medical University",
                    "location": {
                        "postCode": "150081",
                        "settlement": "Harbin, Heilongjiang",
                        "country": "China"
                    }
                },
                "email": "kaijiangyu002@163.com"
            }
        ]
    },
    "abstract": [
        {
            "text": "The global outbreak of COVID-19 has seriously endangered healthcare systems in China and worldwide. 15.7% of cases of COVID-19 were severe, and 5% were critical according to guidelines on the diagnosis and treatment of new coronavirus pneumonia (version 6) [1]. One recent study reported that the fatality rate of COVID-19 in China is 1.4% [2]. Despite showing a lower case fatality rate, COVID-19 has so far resulted in more deaths than SARS and MERS combined [3, 4] . It is important to establish whether there is a difference between severe and critical patients, as this might help us to identify critical patients in a more timely and effective manner. However, to date, few biomarkers of progression of COVID-19 have been reported.",
            "cite_spans": [
                {
                    "start": 465,
                    "end": 467,
                    "text": "4]",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "In this single-center retrospective study, written informed consent was duly obtained from all patients. The study was approved by the Ethics Committee of the first affiliated hospital of Harbin Medical University. A total of 45 COVID-19 patients were included. Our study defined the severity of COVID-19 according to the guidelines on the diagnosis and treatment of new coronavirus pneumonia (version 6). We also attempted to evaluate the severity of COVID-19 patients using the sequential organ failure assessment (SOFA) scoring system. A logistic regression model was used to analyze the factors influencing the severity of the disease. Among the total of 19 adjustable variables (seen in supplementary data) in the univariate analysis, 3 and 2 significant indicators were found two different evaluation systems, respectively. In addition to using these indicators, comorbidities, age, and sex were also included in the model for multivariate regression analysis.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "The patients' baseline characteristics were compared between the severe and the critical group according to the two different evaluation systems. Classification according to version 6 (eTable-1): among 33 severe patients (mean age 63.13 \u00b1 14.1 years), 17 [52%] were male; among 12 critical patients mean age (62.58 \u00b1 9.89 years), 6 [50%] were male. IL-6 levels ( Fig. 1a) (p = 0.0004) and IL-10 levels (eFig. 2) (p = 0.0073) were significantly lower in the severe group than in the critical group (eTable 1); the results showed that IL-6 levels (Fig. 1b , eTable 2-4) were related to the severity of COVID patients (p = 0.0121). The AUC of IL-6 was 0.848, the sensitivity 90.91%, the specificity 66.67%, and the cutoff value 19.03 pg/ml. Classification according to the SOFA score system (Severe: SOFA < 2; Critical: SOFA \u2265 2) (eTable 5): among 14 severe patients (mean age 57.69 \u00b1 19.34 years), 8 [57%] were male; among 31 critical patients (mean age 65.19 \u00b1 8.63 years), 15 [48%] were male. Lower IL-6 levels ( Fig. 1c) (p < 0.0001) and higher CD3 (eFig. 3) (p = 0.0032) were found in the severe group compared with the critical group. The results (see supplementary data) showed that IL-6 levels (Fig. 1d , eTable 6-8) were related to the severity of COVID patients (p = 0.0151). The AUC of IL-6 was 0.910, the sensitivity 85.71%, the specificity 96.77%, and the cutoff value 6.11 pg/ml.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 363,
                    "end": 371,
                    "text": "Fig. 1a)",
                    "ref_id": null
                },
                {
                    "start": 545,
                    "end": 553,
                    "text": "(Fig. 1b",
                    "ref_id": null
                },
                {
                    "start": 1013,
                    "end": 1021,
                    "text": "Fig. 1c)",
                    "ref_id": null
                },
                {
                    "start": 1199,
                    "end": 1207,
                    "text": "(Fig. 1d",
                    "ref_id": null
                }
            ],
            "section": "Abstract"
        },
        {
            "text": "In conclusion, up-regulated IL-6 levels may serve as a potential marker for predicting progression of COVID-19 patients. Whether evaluated according to the version 6 guidelines or the SOFA score, IL-6 is good at assessing COVID-19 progression.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "The global outbreak of COVID-19 has seriously endangered healthcare systems in China and worldwide. 15.7% of cases of COVID-19 were severe, and 5% were critical according to guidelines on the diagnosis and treatment of new coronavirus pneumonia (version 6) [1] . One recent study reported that the fatality rate of COVID-19 in China is 1.4% [2] . Despite showing a lower case fatality rate, COVID-19 has so far resulted in more deaths than SARS and MERS combined [3, 4] . It is important to establish whether there is a difference between severe and critical patients, as this might help us to identify critical patients in a more timely and effective manner. However, to date, few biomarkers of progression of COVID-19 have been reported.",
            "cite_spans": [
                {
                    "start": 257,
                    "end": 260,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 341,
                    "end": 344,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 463,
                    "end": 466,
                    "text": "[3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 467,
                    "end": 469,
                    "text": "4]",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "In this single-center retrospective study, written informed consent was duly obtained from all patients. The study was approved by the Ethics Committee of the first affiliated hospital of Harbin Medical University. A total of 45 COVID-19 patients were included. Our study defined the severity of COVID-19 according to the guidelines on the diagnosis and treatment of new coronavirus pneumonia (version 6). We also attempted to evaluate the severity of COVID-19 patients using the sequential organ failure assessment (SOFA) scoring system. A logistic regression model was used to analyze the factors influencing the severity of the disease. Among the total of 19 adjustable variables (seen in supplementary data) in the univariate analysis, 3 and 2 significant indicators were found two different evaluation systems, respectively. In addition to using these indicators, comorbidities, age, and sex were also included in the model for multivariate regression analysis.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "The patients' baseline characteristics were compared between the severe and the critical group according to the two different evaluation systems. Classification according to version 6 (eTable-1): among 33 severe patients (mean age 63.13 \u00b1 14.1 years), 17 [52%] were male; among 12 critical patients mean age (62.58 \u00b1 9.89 years), 6 [50%] were male. IL-6 levels ( Fig. 1a) (p = 0.0004) and IL-10 levels (eFig. 2) (p = 0.0073) were significantly lower in the severe group than in the critical group (eTable 1); the results showed that IL-6 levels (Fig. 1b , eTable 2-4) were related to the severity of COVID patients (p = 0.0121). The AUC of IL-6 was 0.848, the sensitivity 90.91%, the specificity 66.67%, and the cutoff value 19.03 pg/ml. Classification according to the SOFA score system (Severe: SOFA < 2; Critical: SOFA \u2265 2) (eTable 5): among 14 severe patients (mean age 57.69 \u00b1 19.34 years), 8 [57%] were male; among 31 critical patients (mean age 65.19 \u00b1 8.63 years), 15 [48%] were male. Lower IL-6 levels ( Fig. 1c) (p < 0.0001) and higher CD3 (eFig. 3) (p = 0.0032) were found in the severe group compared with the critical group. The results (see supplementary data) showed that IL-6 levels (Fig. 1d, eTable 6-8) were related to the severity of COVID patients (p = 0.0151). The AUC of IL-6 was 0.910, the sensitivity 85.71%, the specificity 96.77%, and the cutoff value 6.11 pg/ml.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 363,
                    "end": 371,
                    "text": "Fig. 1a)",
                    "ref_id": null
                },
                {
                    "start": 545,
                    "end": 553,
                    "text": "(Fig. 1b",
                    "ref_id": null
                },
                {
                    "start": 1013,
                    "end": 1021,
                    "text": "Fig. 1c)",
                    "ref_id": null
                },
                {
                    "start": 1199,
                    "end": 1220,
                    "text": "(Fig. 1d, eTable 6-8)",
                    "ref_id": null
                }
            ],
            "section": ""
        },
        {
            "text": "In conclusion, up-regulated IL-6 levels may serve as a potential marker for predicting progression of COVID-19 patients. Whether evaluated according to the version 6 guidelines or the SOFA score, IL-6 is good at assessing COVID-19 progression. Fig. 1 IL-6 levels (p = 0.0004) a was significantly lower in severe group than critical group due to Guidelines of the Diagnosis and Treatment of New Coronavirus Pneumonia (version 6), AUC of IL-6 is 0.848, sensitivity is 90.91%, specificity is 66.67% (b); IL-6 levels (p < 0.0001), c was significantly different in two disease groups due to SOFA scoring system., AUC of IL-6 is 0.910, sensitivity is 85.71%, specificity is 96.77% (d)",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 244,
                    "end": 250,
                    "text": "Fig. 1",
                    "ref_id": null
                }
            ],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Mahase",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "BMJ",
            "volume": "368",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Clinical Characteristics of Coronavirus Disease 2019 in China",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "Y"
                    ],
                    "last": "Ni",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "Q"
                    ],
                    "last": "Ou",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "X"
                    ],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shan",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Lei",
                    "suffix": ""
                },
                {
                    "first": "Dsc",
                    "middle": [],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "J"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Zeng",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "Y"
                    ],
                    "last": "Yuen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "Y"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xiang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "J"
                    ],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "X"
                    ],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "J"
                    ],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Q"
                    ],
                    "last": "Qiu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "S"
                    ],
                    "last": "Zhong",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2002032"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Frequently asked questions about SARS",
            "authors": [],
            "year": 2019,
            "venue": "Centers for Disease Control and Prevention",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Middle East respiratory syndrome coronavirus (MERS-CoV",
            "authors": [],
            "year": 2019,
            "venue": "World Health Organization",
            "volume": "30",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {},
    "back_matter": [
        {
            "text": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Accepted: 18 April 2020",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Publisher's Note"
        }
    ]
}